Bioinformatic analysis of benzo-α-pyrene-induced damage to the human placental insulin-like growth factor-1 gene

Reproductive Sciences

Volumn 20, Issue 8, 2013, Pages 917-928

  Fadiel, A ^a,b   Epperson, B ^b   Shaw, M I ^a,c   Hamza, A ^d   Petito, J ^a   Naftolin, F ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

benzo pyrene (B P); bioinformatics; fetal growth restriction (FGR); IGF 1; intrauterine growth restriction (IUGR); polycyclic aromatic hydrocarbons

Indexed keywords

BENZO ALPHA PYRENE; POLYCYCLIC AROMATIC HYDROCARBON; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; EXON; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE MUTATION; INTRAUTERINE GROWTH RETARDATION; OPEN READING FRAME; PLACENTA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FOLDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMULATION; START CODON; TROPHOBLAST; UMBILICAL CORD BLOOD;

BENZO-Α-PYRENE (BΑP); BIOINFORMATICS; FETAL GROWTH RESTRICTION (FGR); IGF-1; INTRAUTERINE GROWTH RESTRICTION (IUGR); POLYCYCLIC AROMATIC HYDROCARBONS;

AMINO ACID SEQUENCE; BASE SEQUENCE; BENZO(A)PYRENE; CELL LINE; CODON, INITIATOR; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; OPEN READING FRAMES; PREGNANCY; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RISK ASSESSMENT; RNA, MESSENGER; TROPHOBLASTS;

EID: 84880438601     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112468946     Document Type: Article

References (66)

1. Rotwein P, Pollock KM, Didier DK, Krivi GG. Organization and sequence of the human insulin-like growth factor I gene: alternative RNA processing produces two insulin-like growth factor-I precursor peptides. J Biol Chem. 1986 ; 261 (11). 4828-4832
2. Léger J, Oury JF, Noel M, et al. Growth factors and intrauterine growth retardation. Serum growth hormone, insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein 3 levels in normally grown and growth-retarded human fetuses during the second half of genstation. Pediatr Res.. 1996 ; 40 (1). 94-100
3. Liu JL, LeRoith D. Insulin-like growth factor-1 is essential for postnatal growth in response to growth hormone. Endocrinology. 1999 ; 140 (11). 5178-5184
4. Kaku K, Osada H, Seki K, Sekiya S. Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth. Acta Paediatr. 2007 ; 96 (3). 363-367
5. McIntyre HD, Serek R, Crane DI, et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab.. 2000 ; 85 (3). 1143-1150
6. Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal IGF-1 by placental GH in normal and abnormal human pregnancies. Am J Physiol. 1993 ; 265 (4 pt 1). E572 - E577
7. Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple pregnancy. J Clin Endocrinol Metab. 1995 ; 80 (1). 21-27
8. Liu JL, Grinberg A, Westphal H, et al. Insulin-like growth factor-1 affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol. 1998 ; 12 (9). 1452-1462
9. Bach MA, Roberts CT, Smith EP, LeRoith D. Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro. Mol Endocrinol. 1990 ; 4 (6). 899-904
10. Chew SL, Lavender P, Clark AJ, Ross RJ. An alternatively spliced human insulin-like growth factor-1 transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology. 1995 ; 136 (5). 1939-1944
11. Powell-Braxton L, Hollingshead P, Giltinan D, Pitts-Meek S, Stewart T. Inactivation of the IGF-1 gene in mice results in perinatal lethality. Ann NY Acad Sci. 1993 ; 692: 300-301
12. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab. 2002 ; 87 (6). 2720-2724
13. Camacho-Hübner C, Woods KA, Clark AJ, Savage MO. Insulin-like growth factor (IGF)-1 gene deletion. Endocrinol Metab Disorder. 2002 ; 3: 357-361
14. Johnson LB, Legert J, Savage MO. The insulin like growth factor 1 (IGF-1) gene in individuals born small for gestational age (SGA). Clin Endocrinol (Oxf). 1999 ; 51 (4). 423-427
15. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-1 and low birth weight. Lancet. 2002 ; 359 (9311). 1036-1037
16. Walenkamp MJ, van der Kamp HJ, Pereira AM, et al. A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab. 2006 ; 91 (8). 3062-3070
17. Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO. IGF-1 gene deletion causing intrauterine growth restriction and severe short stature. Acta Paediatr Suppl. 1997 ; 423: 39-45
18. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal failure associated with deletion of the insulin-like growth factor-1 gene. N Engl J Med. 1996 ; 335 (18). 1363-1367
19. Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. Br Med J. 1990 ; 301 (6746). 259-262
20. Ostlund E, Bang P, Hagenas L, Fried G. Insulin-like growth factor-1 in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation. Hum Reprod. 1997 ; 12 (4). 840-844
21. Bondy CA, Werner H, Roberts CT. Cellular pattern of insulin-like growth factor I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol. 1990 ; 4 (9). 1386-1398
22. Lewinski A, Marcinkowska M, Brzezianska E, Jeziorowska A, Wloch J. Expression of insulin-like growth factor-I (IGF-I) gene and of genes for IGF-binding proteins 1, 2, 3, 4 (IGFBP-1-IGFBP-4) in non-neoplastic human thyroid cells and in certain human thyroid cancers: effect of exogenous IGF-I on this expression. Endocr Res. 1990 ; 30 (1). 47-59
23. Abuzzahab MJ, Schneider A, Goddard A, et al. Intrauterine Growth Retardation (IUGR) Study Group. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med.. 2003 ; 349 (23). 2211-2222
24. Kawashima Y, Kanzaki S, Yang F, et al. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab. 2005 ; 90 (8). 4679-4687
25. Laviola L, Perrini S. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005 ; 146 (3). 1488-1505
26. Boyne MS, Thame M, Bennett FI, Osmond C, Miell JP, Forrester TE. The relationship of insulin like growth factor (IGF-1), IGF-binding proteins 1- and -2 and birth anthropometry: a prospective study. J Clin Endocrinol Metab. 2003 ; 88 (4). 1687-1691
27. Fant M, Salafia C, Baxter RC, et al. Circulating level IGFs and IGF binding proteins in human cord serum relationships to intrauterine growth. Regul Pept. 1993 ; 48 (1-2). 29-39
28. Guidice LC, de Zegher F, Gargosky SE. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 1995 ; 80 (5). 1548-1555
29. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. C-peptide, insulin-like growth factors I and II and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol. 1993 ; 169 (1). 89-97
30. Domené HM, Bengolea SV, Jasper HG, Boisclair YR. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest. 2005 ; 28 (5 suppl). 43-46
31. Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: identification and management. Am Fam Physician. 1998 ; 58 (2). 453-460
32. Bernstein I, Gabbe SG Intrauterine Growth Restriction, in Obstetrics: Normal and Problem Pregnancies. Gabbe S, ed. New York, NY: Churchill Livingstone ; 1998: 863-886.
33. Estimates of National Institute of Child Health and Human Development. National Institutes of Health; 2003.
34. Williams. Obstetrics. 21st ed, Cunningham G, et al., ed. New York, NY: McGraw-Hill; 2001.
35. Barker DJ. The long-term outcome of retarded fetal growth. Clin Obstet Gynecol. 1997 ; 40 (4). 853-863
36. Creasy RK, Resnik R Maternal-Fetal Medicine. 4 th ed. Philadelphia, PA: W.B. Saunders; 1999. Philadelphia, PA: W.B. Saunders ; 1999:
37. Hack M, Taylor HG, Klein N, Eiben R, Schatschneider C, Mercuri-Minich N. School-age outcomes in children with birth weights under 750 g. N Engl J Med. 1994 ; 331 (12). 753-759
38. Powls A, Botting N, Cooke RW. Visual impairment in very low birthweight children. Arch Dis Child Fetal Neonatal Ed. 1997 ; 76 (2). F82 - F87
39. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ. 1993 ; 307 (6918). 1524-1527
40. Fall CH, Barker DJ, Osmond C, Winter PD, Clark PM, Hales CN. Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease. BMJ. 1992 ; 304 (6830). 801-805
41. Martyn CN, Meade TW, Stirling Y, Barker DJ. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. Br J Haematol. 1995 ; 89 (1). 142-146
42. Perera F, Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol. 2011 ; 31 (3). 363-373
43. Stein CE, Kumaran K, Fall CH, Shaheen SO, Osmond C, Barker DJ. Relation of fetal growth to adult lung function in South India. Thorax. 1997 ; 52 (10). 895-899
44. Martyn CN, Barker DJ, Osmond C. Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet. 1996 ; 348 (9037). 1264-1268
45. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993 ; 36 (1). 62-67
46. Cooper C, Eriksson JG, Forsen T, Osmond C, Tuomilehto J, Barker DJ. Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int. 2001 ; 12 (8). 623-629
47. Phillips DI, Barker DJ, Osmond C. Infant feeding, fetal growth and adult thyroid function. Acta Endocrinol (Copenh). 1993 ; 129 (2). 134-138
48. Clark PM, Hindmarsh PC, Shiell AW, Law CM, Honour JW, Barker DJ. Size at birth and adrenocortical function in childhood. Clin Endocrinol (Oxf). 1996 ; 45 (6). 721-726
49. Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI, Fraser RB. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet. 1997 ; 350 (9085). 1131-1135
50. Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control. 1997 ; 8 (6). 904-912
51. Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G, Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res. 1993 ; 34 (4). 439-442
52. Verhaeghe J, Loos R, Vlietinck R, Herck EV, van Bree R, Schutter AM. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: Genetic versus environmental regulation. Am J Obstet Gynecol. 1996 ; 175 (5). 1180-1188
53. Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect. 2000 ; 108 (12). 1159-1164
54. Rappolee DA, Awonuga AO, Puscheck EE, Zhou S, Xie Y. Benzopyrene and experimental stressors cause compensatory differentiation in placental trophoblast stem cells. Syst Biol Reprod Med. 2010 ; 56 (2). 168-183
55. Everson RB, Randerath E, Snatella RM, Avitts TA, Weinstein IB, Randerath K. Quantitative association between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst. 1988 ; 80 (8). 567-575
56. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998 ; 179 (4). 1051-1055
57. Savitz DA, Dole N, Terry JW, Zhou H, Thorp JM. Smoking and pregnancy outcome among African-American and white women in central North Carolina. Epidemiology. 2001 ; 12 (6). 636-642
58. Everson RB, Randerath E, Santella RM, Cefalo RC, Avitts TA, Randerath K. Detection of smoking-related covalent DNA-adducts in human placenta. Science. 1986 ; 231 (4733). 54-57
59. Manchester DK, Wilson VL, Hsu IC, et al. Synchronous fluorescence spectroscopic, immunoaffinity chromatographic, and32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. Carcinogenesis. 1990 ; 11 (4). 553-559
60. Manchester DK, Weston A, Choi JS, et al. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci U S A. 1988 ; 85 (23). 9243-9247
61. Eisenstadt E, Warren AJ, Porter J, Atkins D, Miller JH. Carcinogenic epoxides of benzo[a]pyrene and cyclopenta (c, d) pyrene induce base substitution. Proc Natl Acad Sci U S A. 1982 ; 79 (6). 1945-1949
62. Feng B, Gorin A, Kolbanovskiy A, et al. Solution conformation of the (-)-trans-anti-[BP]dG adduct opposite a deletion site in a DNA duplex: intercalation of the covalently attached benzo [a]pyrene into the helix with base displacement of the modified deoxyguanosine into the minor groove. Biochemistry. 1997 ; 36 (45). 13780-13790
63. Haseltine WA, Lo KM, D'Andrea AD. Preferred sites of strand scission in DNA modified by anti-diol epoxide of benzo[a]pyrene. Science. 1980 ; 209 (4459). 929-931
64. Wei SJ, Chang RL, Bhachech N, et al. Dose dependent differences in the profile of mutations induced by (+)-7R, 8 S dihydroxy- 9 S,10R-epoxy-7,8,9,10- tetrahydro-benzo[a]pyrene in the coding region of the hypoxanthine (Guanine) phosphoribosyl-ransferase gene in chinese hamster V79 cells. Cancer Res. 1993 ; 53 (14). 3294-3301
65. Meade ES, Ma YY, Guller S.. Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line. Placenta. 2007 ; 28 (10). 1012-1019
66. Zar JH.. Significance testing of spearman rank correlation coefficient. J Am Stat Assoc. 1972 ; 67 ( 339 ):